Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01116674 · ClinicalTrials.gov registry record
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 206
- Enrollment target
NCT01116674: Completed study, sponsored by Indiana University.
NCT01116674 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 206 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01116674 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 206 participants
- Enrollment target
Study Summary
The objective in this project is to assemble a consortium of pediatric critical care centers of varying size, acuity, and composition to evaluate our glycemic control protocol on at least 250 children with hyperglycemia in different critical care units. \*\*\*This Study is supported by an R21 Grant (MRR) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Primary Outcome
Determine safety (ie hypoglycemia) and effectiveness (ie ability to establish/maintain glycemic control) of our pedatric-specific approach to control critical illness hyperglycemia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2010-05 |
| Est. Completion | 2014-12 |
What the finished NCT01116674 record still lists
NCT01116674 is an observational study that tracks outcomes without assigning an intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01116674 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01116674 about?
NCT01116674 is a clinical study titled "Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry". The objective in this project is to assemble a consortium of pediatric critical care centers of varying size, acuity, and composition to evaluate our glycemic control protocol on at least 250 children with hyperglycemia in different critical care units. \*\*\*This Study is supported by an R21 Grant...
What is the current status of trial NCT01116674?
This trial is currently completed. The enrollment target is 206 participants. The study started on 2010-05. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01116674?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03373968 · 206 participants · Phase 2
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
- NCT03550391 · 206 participants · Phase 3
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- NCT04757116 · 206 participants · NA
Post-Market Study to Assess iTind Safety in Comparison to UroLift
- NCT05675865 · 206 participants · NA
Cryoablation for Monomorphic Ventricular Tachycardia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia